These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6330650)

  • 1. [Resistance of Enterobacteria to cefotaxime and lamoxactam at the Pitié-Salpêtrière Hospital in 1982].
    Nicolas MH; Jarlier V; Fievet MH; Nguyen J; Truffot C
    Pathol Biol (Paris); 1984 May; 32(5):393-5. PubMed ID: 6330650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Enterobacter cloacae. In vivo emergence of a variant resistant to new beta-lactams during treatment with lamoxactam-gentamicin].
    Jarlier V; Philippon A; Nicolas MH; Bismuth R; Paul G; Fusciardi J
    Pathol Biol (Paris); 1984 May; 32(5):399-403. PubMed ID: 6739148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cefotaxime, moxalactam and ceftriaxone: comparison of in vitro activity against hospital strains of Enterobacteriaceae belonging to the 4 principal phenotypes of sensitivity to beta-lactams].
    Jarlier V; Bismuth R; Grosset J
    Pathol Biol (Paris); 1983 May; 31(5):336-42. PubMed ID: 6312393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro activity of combinations of cefotaxime and moxalactam with aminoglycosides on beta-lactamase-producing Enterobacteriaceae].
    Sirot J; Sirot D; Garnier R; Joly B; Cluzel R
    Pathol Biol (Paris); 1983 Jun; 31(6):480-2. PubMed ID: 6308542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [In vitro activity of cefotaxime, latamoxef and ceftriaxone on hospital strains of Enterobacteriaceae resistant to cefalotine and cefoxitine].
    Berche P; Gaillard JL
    Ann Biol Clin (Paris); 1986; 44(6):624-7. PubMed ID: 3826779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survey of the phenotypes of susceptibility to beta-lactams in Enterobacteriaceae at the Pitie-Salpetriere Hospital.
    Jarlier V; Bismuth R; Nicolas MH; Nguyen J; Truffot C; Grosset J
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():59-65. PubMed ID: 6501135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of temocillin, moxalactam and cefotaxime against gram negative bacteria sensitive or resistant to ureidopenicillins and/or cefacedone.
    Bartmann K; Tarbuc R
    Zentralbl Bakteriol Mikrobiol Hyg A; 1983 Dec; 256(2):202-10. PubMed ID: 6324518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
    Lewis JS; Herrera M; Wickes B; Patterson JE; Jorgensen JH
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of Beta-lactamase resistance in enterobacteria].
    Koren J; Vaculíková A
    Klin Mikrobiol Infekc Lek; 2006 Jun; 12(3):103-7. PubMed ID: 17051471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population analysis of susceptibility to cefotaxime in Enterobacteriaceae.
    Søgaard P
    Acta Pathol Microbiol Immunol Scand B; 1985 Oct; 93(5):365-9. PubMed ID: 4083013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sensitivity to fosfomycin of bacteria isolated at the Pitié-Salpétrière Hospital in 1982 and 1983].
    Bismuth R; Jarlier V; Nicolas MH; Nguyen J; Truffot C
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):520-4. PubMed ID: 6431379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro activity of cefatiolene (RP 42,980) against hospital bacteria. Comparison with cefotaxime and lamoxactam. Results of a multicenter study].
    Duval J; Soussy CJ; Deforges L; Le Van Thoi J; Acar JF; Kitzis D; Dabernat H; Christol D; Bure A; Courtieu AL
    Pathol Biol (Paris); 1983 May; 31(5):357-61. PubMed ID: 6312397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro evaluation of moxalactam on enterobacteria producing beta-lactamases].
    Kazmierczak A; Pechinot A; Duez JM; Kohli E; Tremeaux JC
    Sem Hop; 1983 Jun; 59(26):1953-7. PubMed ID: 6310785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spread of novel expanded-spectrum beta-lactamases in Enterobacteriaceae in a university hospital in the Paris area, France.
    Lartigue MF; Fortineau N; Nordmann P
    Clin Microbiol Infect; 2005 Jul; 11(7):588-91. PubMed ID: 15966981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Susceptibility of clinical isolates to cefotaxime. Comparison to new antibiotics latamoxef, cefoperazone, and ceftizoxime].
    Asari S; Horikawa M; Tsukamoto H; Shimizu Y; Koda K; Hayashi C; Miyai K
    Jpn J Antibiot; 1984 Feb; 37(2):267-78. PubMed ID: 6330393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological study of Enterobacter cloacae resistant to 3rd generation cephalosporins: a preliminary report.
    Giamarellou H; Koratzanis G; Kanellakopoulou K; Daikos GK
    Chemioterapia; 1985 Feb; 4(1):43-6. PubMed ID: 3986944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of cefotaxime and amikacin against 14,272 gram-negative bacteria from clinical samples in the period 1980 to 1985.
    Dámaso D; Sánchez-Moreno MP; Martínez-Martínez L; Mesa E; Portero F; Mendaza P; Daza RM
    Drugs; 1988; 35 Suppl 2():1-5. PubMed ID: 3396470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Enterobacteriaceae isolated in nine general hospitals of the Ile-de-France in 1988 and 1989: susceptibility to beta-lactam antibiotics according to the length of hospitalisation].
    Pean Y; Hacquard B; Berardi-Grassias L; Boisivon A; Bejot J; Eme A; Le Pennec MP; Morice J; Rouchon M; Gertner J
    Pathol Biol (Paris); 1991 May; 39(5):486-8. PubMed ID: 1881679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of CHROMagar CTX, a novel medium for isolating CTX-M-ESBL-positive Enterobacteriaceae while inhibiting AmpC-producing strains.
    Randall LP; Kirchner M; Teale CJ; Coldham NG; Liebana E; Clifton-Hadley F
    J Antimicrob Chemother; 2009 Feb; 63(2):302-8. PubMed ID: 19043079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of multiresistance on the minimal inhibitory concentration of N-formimidoyl thienamycin and 6 comparing substances against P. aeruginosa and 4 Enterobacteriaceae species].
    Schröter G; Schrettenbrunner A; Strenzel I
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Feb; 253(4):531-43. PubMed ID: 6407236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.